株探米国株
日本語 英語
エドガーで原本を確認する
FALSE000073101200007310122024-02-142024-02-14

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 14, 2024

HCSG_Logo No Tagline.jpg

HEALTHCARE SERVICES GROUP, INC.
(Exact name of registrant as specified in its charter)

Commission File Number: 0-12015
Pennsylvania 23-2018365
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification number)

3220 Tillman Drive, Suite 300, Bensalem, Pennsylvania
(Address of principal executive office)

19020
(Zip Code)

Registrant's telephone number, including area code: 215-639-4274
    
Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
( ☐ )    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
( ☐ )    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
( ☐ )    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
( ☐ )    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $.01 par value HCSG NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o On February 14, 2024, Healthcare Services Group, Inc. (the "Company") issued a press release (the "Press Release") announcing its earnings for the three months and year ended December 31, 2023. A copy of the Press Release is being furnished hereto as Exhibit 99.1 and is hereby incorporated by reference to this Current Report.



Item 2.02 Results of Operations and Financial Condition.


The information furnished herein, including Exhibit 99.1 shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act.

Item 9.01 Financial Statements and Exhibits

( a )    Not applicable
( b )    Not applicable
( c )    Not applicable
( d )    Exhibits.
Exhibit Number Description
99.1
104 Cover page Interactive Data File (embedded within the Inline XBRL document)





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

HEALTHCARE SERVICES GROUP, INC.
Date: February 14, 2024 By: /s/ Andrew M. Brophy
Name: Andrew M. Brophy
Title: Vice President, Controller & Principal Accounting Officer

EX-99.1 2 ex99-2023xq4xpressrelease.htm EX-99.1 Document
Exhibit 99.1
HCSG Reports Q4 2023 Results
Exceeds Earnings and Cash Flow Expectations, Revenue In-Line

•Revenue of $423.8 million; adjusted revenue(1) of $425.0 million, in-line with expectations.
•Net income and diluted EPS of $22.6 million and $0.31; adjusted net income(1) and adjusted diluted EPS(1) of $14.6 million and $0.20.
•Adjusted EBITDA(1) of $26.5 million, a 14.2% increase over Q4 2022.
•Cash flow from operations of $49.5 million; adjusted cash flow from operations(1) of $27.9 million, a 7.1% increase over Q4 2022.

BENSALEM, PA --(BUSINESS WIRE)-- Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended December 31, 2023.

Ted Wahl, Chief Executive Officer, stated, “Our team delivered strong fourth quarter results, building on our momentum throughout 2023. Against the backdrop of an ongoing industry recovery, we achieved 98% cash collections, managed adjusted cost of services under 86%, and exceeded our cash flow projections for the quarter and second half of 2023. We also continued to grow our new business and manager-in-training pipelines, and remain confident that we will deliver on our goal of year-over-year growth in 2024.”

Mr. Wahl continued “Industry operating metrics continue to improve, and a stabilizing labor market and solid reimbursement environment have contributed to the steady occupancy recovery, which now sits at 79.2%, only 100 basis points below pre-pandemic levels. On the regulatory front, there remains uncertainty as to what a final minimum staffing rule may look like and when a decision will be published. We remain hopeful that CMS will fully consider the significant impact on operators before finalizing a rule, and if one is ultimately implemented, have confidence in our customers’ ability to manage in a prudent manner.”

Mr. Wahl concluded, “It’s an incredibly exciting time for the Company, as we’re rounding the turn of what has been a prolonged recovery for the industry. The challenges we navigated the past few years have further solidified our value proposition, the durability of our business model and market leading position. As we enter 2024, the Company’s underlying fundamentals are stronger than ever. With the industry at the beginning of a multi-decade demographic tailwind, we are favorably positioned to capitalize on the opportunities ahead and deliver meaningful, long-term shareholder value.”

Fourth Quarter Highlights
GAAP
Adjusted(1)
Revenue $ 423.8  $ 425.0 
Cost of services $ 350.4  $ 362.6 
Selling, general and administrative $ 46.2  $ 42.2 
Earnings per share $ 0.31  $ 0.20 
Cash flows provided by operating activities $ 49.5  $ 27.9 

•Revenue was $423.8 million; adjusted revenue was $425.0 million, in-line with the Company’s expectations of $420.0 million to $430.0 million. The Company estimates Q1 revenue in the range of $420.0 million to $430.0 million.
•Housekeeping & laundry and dining & nutrition segment revenues were $191.4 million and $232.4 million, respectively; adjusted housekeeping & laundry and dining & nutrition segment revenues were $191.7 million and $233.3 million, respectively.


Exhibit 99.1
•Housekeeping & laundry and dining & nutrition segment margins were 7.5% and 6.2%, respectively; adjusted housekeeping & laundry and dining & nutrition segment margins were 7.7% and 6.6%, respectively.
•Cost of services was $350.4 million; adjusted cost of services was $362.6 million, or 85.3%. The Company’s goal is to continue to manage adjusted cost of services in the 86% range.
•SG&A was $46.2 million; adjusted SG&A was $42.2 million, or 9.9%. The Company’s goal continues to be achieving adjusted SG&A in the 8.5% to 9.5% range.
•Diluted EPS was $0.31 per share; adjusted diluted EPS was $0.20 per share.

Balance Sheet and Liquidity

The Company’s primary sources of liquidity are cash and cash equivalents, its revolving credit facility, and cash flow from operating activities. As of the end of the fourth quarter, the Company had a current ratio of 2.6 to 1, cash and marketable securities of $147.5 million, and a $500.0 million credit facility, which expires in November 2027. Additionally, Q4 cash flow and adjusted cash flow from operations were $49.5 million and $27.9 million, respectively. During the second half of 2023, cash flow from operations was $52.4 million, exceeding the previously raised expected range of $35.0 million to $45.0 million.

The Company repurchased over one million shares, or $11.2 million, of its common stock during 2023, including over 0.5 million shares, or $5.0 million, of its common stock during the fourth quarter. The Company has 6.5 million shares remaining under its outstanding share repurchase authorization.

Conference Call and Upcoming Events

The Company will be attending and participating in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference, which will be conducted virtually on March 13, 2024.

The Company will host a conference call on Wednesday, February 14, 2024, at 8:30 a.m. Eastern Time to discuss its results for the three months ended December 31, 2023. The call may be accessed via phone at 1 (888) 330-3451, Conference ID: 4431380. The call will be simultaneously webcast under the “Events & Presentations” section of the Investor Relations page on the Company’s website, www.hcsg.com. A replay of the webcast will also be available on the website for one year following the date of the earnings call.

(1) Adjusted results are non-GAAP financial measures and exclude the impact of certain items. See the tables within "Reconciliations of Non-GAAP Financial Measures" for more information.








Exhibit 99.1
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This release and any schedules incorporated by reference into it may contain forward-looking statements within the meaning of federal securities laws, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as “believes,” “anticipates,” “plans,” “expects,” “estimates,” “will,” “goal,” and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services to the healthcare industry and primarily providers of long-term care; the impact of and future effects of the COVID-19 pandemic or other potential pandemics; having a significant portion of our consolidated revenues contributed by one customer during the year ended December 31, 2023; credit and collection risks associated with the healthcare industry; the impact of bank failures; our claims experience related to workers’ compensation and general liability insurance (including any litigation claims, enforcement actions, regulatory actions and investigations arising from personal injury and loss of life related to COVID-19); the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; the Company's expectations with respect to selling, general and administrative expense; and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2022 under “Government Regulation of Clients,” “Service Agreements and Collections,” and “Competition” and under Item 1A. “Risk Factors” in such Form 10-K.

These factors, in addition to delays in payments from customers and/or customers in bankruptcy, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results have been, and would continue to be, adversely affected by continued inflation particularly if increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs and COVID-19) cannot be passed on to our customers.

In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies. There can be no assurance that we will be successful in that regard.

USE OF NON-GAAP FINANCIAL INFORMATION

To supplement HCSG’s consolidated financial information, which are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”), the Company believes that certain non-GAAP financial measures are useful in evaluating operating performance and comparing such performance to other companies.

The Company is presenting adjusted revenues, adjusted segment revenues, adjusted segment margins, adjusted costs of services provided, adjusted selling, general and administrative expense, adjusted net income, adjusted diluted earnings per share, adjusted cash flows provided by (used in) operations, earnings before interest, taxes, depreciation and amortization ("EBITDA"), and EBITDA excluding items impacting comparability ("Adjusted EBITDA"). We cannot provide a reconciliation of forward-looking non-GAAP measures to GAAP due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. The presentation of non-GAAP financial measures is not meant to be considered in isolation or as a substitute for financial statements prepared in accordance with GAAP.

Company Contacts:
Theodore Wahl Matthew J. McKee
President and Chief Executive Officer Chief Communications Officer
215-639-4274
investor-relations@hcsgcorp.com



Exhibit 99.1
HEALTHCARE SERVICES GROUP, INC.
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(in thousands, except per share data)

For the Three Months Ended For the Year Ended
December 31, December 31,
2023 2022 2023 2022
Revenues $ 423,840  $ 424,020  $ 1,671,389  $ 1,690,176 
Operating costs and expenses:
Cost of services 350,383  366,810  1,456,643  1,496,865 
Selling, general and administrative 46,249  39,524  166,772  140,344 
Income from operations 27,208  17,686  47,974  52,967 
Other income (expense), net: 3,833  2,372  5,082  (8,414)
Income before income taxes 31,041  20,058  53,056  44,553 
Income tax provision 8,443  3,899  14,670  10,310 
Net income $ 22,598  $ 16,159  $ 38,386  $ 34,243 
Basic earnings per common share $ 0.31  $ 0.22  $ 0.52  $ 0.46 
Diluted earnings per common share $ 0.31  $ 0.22  $ 0.52  $ 0.46 
Basic weighted average number of common shares outstanding 73,817  74,342  74,288  74,336 
Diluted weighted average number of common shares outstanding 73,879  74,367  74,340  74,351 




Exhibit 99.1
HEALTHCARE SERVICES GROUP, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(in thousands)
December 31, 2023 December 31, 2022
Cash and cash equivalents $ 54,330  $ 26,279 
Marketable securities, at fair value 93,131  95,200 
Accounts and notes receivable, net 383,509  336,777 
Other current assets 40,726  50,376 
Total current assets 571,696  508,632 
Property and equipment, net 28,774  22,975 
Notes receivable — long-term, net 24,832  32,609 
Goodwill 75,529  75,529 
Other intangible assets, net 12,127  15,946 
Deferred compensation funding 40,812  33,493 
Other assets 36,882  31,652 
Total Assets $ 790,652  $ 720,836 
Accrued insurance claims — current $ 22,681  $ 23,166 
Other current liabilities 194,247  165,848 
Total current liabilities 216,928  189,014 
Accrued insurance claims — long-term 61,697  65,541 
Deferred compensation liability — long-term 41,186  33,764 
Lease liability — long-term 11,235  8,097 
Other long term liabilities 2,990  6,141 
Stockholders' equity 456,616  418,279 
Total liabilities and stockholders' equity $ 790,652  $ 720,836 







Exhibit 99.1
HEALTHCARE SERVICES GROUP, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
(Unaudited)

Reconciliation of GAAP revenue to adjusted revenue (in thousands) For the Three Months Ended For the Twelve Months Ended
December 31, December 31,
2023 2022 2023 2022
GAAP revenue $ 423,840  $ 424,020  $ 1,671,389  $ 1,690,176 
Client restructurings1
1,159  —  13,788  10,000 
Adjusted revenue $ 424,999  $ 424,020  $ 1,685,177  $ 1,700,176 

Reconciliation of GAAP costs of services to adjusted costs of services (in thousands) For the Three Months Ended For the Twelve Months Ended
December 31, December 31,
2023 2022 2023 2022
GAAP costs of services $ 350,383  $ 366,810  $ 1,456,643  $ 1,496,865 
Client restructurings1
—  —  9,093  — 
Bad debt expense adjustments2
(347) (6,856) (15,069) (24,948)
Self-insurance adjustments3
12,534  9,805  12,534  9,805 
Adjusted costs of services 362,570  369,759  1,463,201  1,481,722 
Adjusted costs of services as a percentage of Adjusted revenues 85.3  % 87.2  % 86.8  % 87.2  %

Reconciliation of GAAP selling, general and administrative ("SG&A") to adjusted SG&A (in thousands) For the Three Months Ended For the Twelve Months Ended
December 31, December 31,
2023 2022 2023 2022
GAAP SG&A $ 46,249  $ 39,524  $ 166,772  $ 140,344 
(Gain)/loss on deferred compensation in SG&A4
(4,055) (2,147) (6,685) 9,177 
Adjusted SG&A $ 42,194  $ 37,377  $ 160,087  $ 149,521 
Adjusted SG&A as a percentage of adjusted revenues 9.9  % 8.8  % 9.5  % 8.8  %

Reconciliation of GAAP net income to adjusted net income (in thousands) and earnings per share to adjusted diluted earnings per share For the Three Months Ended For the Twelve Months Ended
December 31, December 31,
2023 2022 2023 2022
GAAP net income $ 22,598  $ 16,159  $ 38,386  $ 34,243 
(Gain)/loss on deferred compensation, net (27) (13) 39  108 
Client restructurings1
1,159  —  22,881  10,000 
Bad debt expense adjustments2
347  6,856  15,069  24,948 
Self-insurance adjustments3
(12,534) (9,805) (12,534) (9,805)
Tax effect of adjustments5
3,007  576  (7,038) (5,853)
Adjusted net income $ 14,550  $ 13,773  $ 56,803  $ 53,641 
Adjusted net income as a percentage of adjusted revenues 3.4  % 3.2  % 3.4  % 3.2  %
GAAP diluted earnings per share $ 0.31  $ 0.22  $ 0.52  $ 0.46 
Adjusted diluted earnings per share $ 0.20  $ 0.19  $ 0.76  $ 0.72 
Weighted-average shares outstanding - diluted 73,879  74,367  74,340  74,351 






Exhibit 99.1
HEALTHCARE SERVICES GROUP, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
(Unaudited)

Reconciliation of GAAP net income to EBITDA and adjusted EBITDA (in thousands) For the Three Months Ended For the Twelve Months Ended
December 31, December 31,
2023 2022 2023 2022
GAAP net income $ 22,598  $ 16,159  $ 38,386  $ 34,243 
Income tax provision 8,443  3,899  14,670  10,310 
Interest, net 509  256  1,628  (1,131)
Depreciation and amortization6
3,779  3,756  14,344  15,316 
EBITDA $ 35,329  $ 24,070  $ 69,028  $ 58,738 
Share-based compensation 2,192  2,058  8,985  9,214 
(Gain)/loss on deferred compensation, net (27) (13) 39  108 
Self-insurance adjustments3
(12,534) (9,805) (12,534) (9,805)
Client restructurings1
1,159  —  22,881  10,000 
Bad debt expense adjustments2
347  6,856  15,069  24,948 
Adjusted EBITDA $ 26,466  $ 23,166  $ 103,468  $ 93,203 
Adjusted EBITDA as a percentage of adjusted revenue 6.2  % 5.5  % 6.2  % 5.5  %

Reconciliation of GAAP cash flows provided by (used in) operations to adjusted cash flows provided by (used in) operations (in thousands) For the Three Months Ended For the Twelve Months Ended
December 31, December 31,
2023 2022 2023 2022
GAAP cash flows provided by (used in) operating activities $ 49,445  $ 22,893  $ 43,498  $ (8,167)
Accrued payroll adjustments7
(21,563) 3,148  (4,186) 23,859 
Adjusted cash flows provided by operating activities $ 27,882  $ 26,041  $ 39,312  $ 15,692 



























Exhibit 99.1
HEALTHCARE SERVICES GROUP, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
(Unaudited)

Reconciliation of GAAP segment margins to adjusted segment revenue and segment margins (in thousands) For the Three Months Ended For the Twelve Months Ended
December 31, December 31,
2023 2022 2023 2022
GAAP revenue - housekeeping $ 191,395  $ 197,977  $ 766,651  $ 795,687 
Client restructurings1 - housekeeping
349  —  4,065  2,289 
Adjusted revenue - housekeeping $ 191,744  $ 197,977  $ 770,716  $ 797,976 
GAAP revenue - dietary $ 232,445  $ 226,043  $ 904,738  $ 894,489 
Client restructurings1 - dietary
810  —  9,723  7,711 
Adjusted revenue - dietary $ 233,255  $ 226,043  $ 914,461  $ 902,200 
Segment margins:
GAAP housekeeping 7.5  % 8.7  % 8.0  % 9.2  %
GAAP dietary 6.2  % 4.3  % 4.8  % 3.2  %
Adjusted housekeeping 7.7  % 8.7  % 8.5  % 9.4  %
Adjusted dietary 6.6  % 4.3  % 5.8  % 4.1  %
1.Client restructurings include changes to contracts with existing customers for which the Company has either recorded a reduction to revenue or an increase to bad debt expense due to clients entering bankruptcy, receivership, or out-of-court workouts.
2.Bad debt expense adjustments reflect the difference between GAAP bad debt expense (CECL) and historical write-offs as a percentage of adjusted revenues, both of which are based on the same seven year look-back period.
3.Self-insurance adjustments reflect changes in the accrued insurance claims liability after considering our updated actuarial estimates for projected incurred losses on past claims.
4.Gain/loss on deferred compensation, net represents the changes in fair market value on deferred compensation investments. The impact of offsetting investment portfolio gains are included in the “Other income (expense), net” caption on the Consolidated Statements of Income.
5.The tax impact of adjustments is calculated using the Company’s effective tax rate for each period end.
6.Depreciation and amortization includes right-of-use asset depreciation of $1.8 million and $6.4 million for the three and twelve months ended December 31, 2023, respectively, and $1.5 million and $6.1 million for the three and twelve months December 31, 2022, respectively.
7.Accrued payroll adjustments reflect changes in accrued payroll for the three and twelve months ended December 31, 2023 and 2022. The Company processes payroll on set weekly and bi-weekly schedules, and the timing of payments may result in operating cash flow increases or decreases which are not indicative of the Company’s quarterly or annual cash flow performance.